Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-1-phenylethyl 2-bromoacetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1046769-20-3

Post Buying Request

1046769-20-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1046769-20-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1046769-20-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,7,6 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1046769-20:
(9*1)+(8*0)+(7*4)+(6*6)+(5*7)+(4*6)+(3*9)+(2*2)+(1*0)=163
163 % 10 = 3
So 1046769-20-3 is a valid CAS Registry Number.

1046769-20-3Downstream Products

1046769-20-3Relevant articles and documents

Discovery and Assessment of Atropisomers of (±)-Lesinurad

Wang, Jianfei,Zeng, Wenqin,Li, Shaohua,Shen, Liang,Gu, Zhengxian,Zhang, Yang,Li, Jian,Chen, Shuhui,Jia, Xiangbo

, p. 299 - 303 (2017)

(+)- and (?)-Lesinurad were isolated as atropisomers from racemic lesinurad for the first time. No interconversion was observed between the two atropisomers under various conditions tested. The two atropisomers showed significant differences in hURAT1 highly expressed HEK293 cell-based inhibition assays, monkey pharmacokinetic studies, and in vitro human recombinant CYP2C9 stability studies. It was speculated that (+)-lesinurad might offer a better hyperuricemia/gout therapy than (?)-lesinurad or the racemate.

Axial chiral isomers and preparation method and pharmaceutical application thereof

-

Paragraph 0123; 0124; 0125, (2016/10/10)

The invention discloses two axial chiral isomers, available medicinal salts thereof, a preparation method thereof, and pharmaceutical application of the two axial chiral isomers or medicinal compositions thereof.

OXAZOLE AND THIAZOLE DERIVATIVES AND THEIR USES 2

-

Page/Page column 66, (2008/12/08)

Compounds of formula (I): wherein A, X, R1, R2, R3, R4, R5, R6 and R8 are as defined in the Specification are useful in the treatment of diseases where enhanced M3 receptor activ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1046769-20-3